Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06324994
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-22
First Post:
2024-03-09
Brief Title:
Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma
Sponsor:
Dalian Medical University
Organization:
Dalian Medical University
Organization Data
Organization:
Dalian Medical University
Class:
OTHER
Study ID:
YY-20394-BV-MCL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dalian Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Xiuhua Sun
Responsible Party Title:
Chief physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Dalian Medical University
Old Name:
None
Old Organization:
None